+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of nasal continuous positive airway pressure treatment on insulin resistance and ghrelin levels in non-diabetic apnoeic patients with coronary heart disease



Effects of nasal continuous positive airway pressure treatment on insulin resistance and ghrelin levels in non-diabetic apnoeic patients with coronary heart disease



Chinese Medical Journal 126(17): 3316-3320



Obesity is a common risk factor for several diseases. Obesity related hormone and increased insulin resistance (IR) may contribute to the effects of obstructive sleep apnoea on cardiovascular consequences. We investigated ghrelin and IR in non-diabetic apnoeic patients with stable coronary heart disease and assessed the effects of continuous positive airway pressure (CPAP). Plasma ghrelin, glucose and insulin were measured in 22 patients with CPAP and 22 matched controls without CPAP at baseline and three months. Indexes including homeostasis model assessment IR (HOMA IR), HOMA S and HOMA β were calculated for the assessment of IR, insulin sensitivity and pancreatic β cell function. At three months follow-up, plasma ghrelin levels and HOMA IR in CPAP group were significantly decreased (P=0.002 and 0.046, respectively) while those in control group increased significantly (P=0.012 and 0.009, respectively). Significant moderate correlations were found between ghrelin vs. HOMA IR and ghrelin vs. HOMA S after CPAP, however, for those without CPAP, no significant associations were observed. Short-term effective continuous positive airway pressure had a significant effect on lowering plasma ghrelin levels and IR, but not body fat. Further large scale and longer term studies are warranted to corroborate these findings.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052877156

Download citation: RISBibTeXText

PMID: 24033956


Related references

Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration; International Review of Thoracic Diseases 79(5): 370-376, 2010

Changes in snoring characteristics after 30 days of nasal continuous positive airway pressure in patients with non-apnoeic snoring: a controlled trial. Thorax 49(6): 562-566, 1994

Non-apnoeic REM sleep induced nocturnal oxygen desaturation treated by nasal continuous positive airway pressure. Thorax 44(6): 521-522, 1989

Long-term effects of continuous positive airway pressure on blood pressure and prognosis in hypertensive patients with coronary heart disease and obstructive sleep apnea: a randomized controlled trial. American Journal of Hypertension 28(3): 300-306, 2015

Effects of continuous positive airway pressure treatment on endothelial function and insulin resistance in patients with obstructive sleep apnea and the metabolic syndrome. 2007

Effects of continuous positive airway pressure on adhesion molecules and P-selectin in coronary heart disease patients with obstructive sleep apnea syndrome. Wuhan Daxue Xuebao (Yixue Ban) 27(5): 588-592, 2006

The effect of nasal continuous positive airway pressure on endothelial function in obstructive sleep apnea-hypopnea syndrome with coronary heart disease. Zhonghua Nei Ke Za Zhi 45(3): 188-191, 2006

A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure. Sleep Medicine 12(2): 147-152, 2011

Comparison of different levels of nasal continuous positive airway pressure in sinus rhythm and atrial fibrillation in patients with severe congestive heart failure. European Respiratory Journal Suppl. 9(23): 19S, 1996

Effects of Continuous Positive Airway Pressure on Lipidaemia and High-sensitivity C-reactive Protein Levels in Non-obese Patients with Coronary Artery Disease and Obstructive Sleep Apnoea. Heart Lung and Circulation 25(6): 576-583, 2016

Is nasal continuous positive airway pressure treatment cost effective? Using a standard economic evaluation checklist as a basis for assessment of a cost effectiveness evaluation of nasal continuous positive airway pressure (nCPAP) treatment. Sleep Medicine 4(5): 473-476, 2003

Choosing an Oronasal Mask to Deliver Continuous Positive Airway Pressure May Cause More Upper Airway Obstruction or Lead to Higher Continuous Positive Airway Pressure Requirements than a Nasal Mask in Some Patients: A Case Series. Journal of Clinical Sleep Medicine 12(9): 1227-1232, 2016

Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study. Pediatrics and Neonatology 56(2): 88-94, 2015

The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea. Diabetes/Metabolism Research and Reviews 28(6): 499-504, 2012

Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis. American Heart Journal 189: 59-67, 2017